# TherOx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/therox

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: http://www.therox.com
- Total disclosed funding: $30M
- Latest round: Series J (Jan 29, 2008)
- Investors on record: 3

## About

TherOx, Inc. is a medical technology company focused on providing innovative solutions for cardiac care through its proprietary TherOx® SuperSaturated Oxygen (SSO2) Therapy, enhancing treatment for patients with ischemic heart conditions.Founded in 1995 and headquartered in Irvine, US, TherOx, Inc. specializes in advanced cardiac therapies. The company has engaged in 7 deals, with its most recent financing round being a USD 15 million Venture Debt in May 2018, led by ZOLL Medical. The firm has remained focused on its core therapy without significant pivoting in operations.TherOx, Inc. delivers the TherOx® SuperSaturated Oxygen (SSO2) Therapy, which is FDA-approved and aimed at reducing myocardial infarct size for patients experiencing ST-Elevation Myocardial Infarction (STEMI). The therapy employs a catheter-based system to provide localized hyperoxemic oxygen levels, enhancing recovery after percutaneous coronary intervention (PCI). TherOx primarily serves hospitals and healthcare providers in the United States and select international markets.In 2007, TherOx, Inc. reported a revenue of USD 1.007 mn and an EBITDA of USD -9.07 mn, reflecting the financial performance during that year.TherOx, Inc. is looking to expand its product offerings, focusing on enhancements to its SSO2 Therapy systems. The recent funding of USD 15 million will be allocated towards developing new technological advancements and expanding into new markets, particularly targeting regions with high incidences of cardiac conditions. The firm plans to leverage these resources to accelerate growth and improve patient outcomes.

## Funding rounds

- Series J, Jan 29, 2008, $30M — Kleiner Perkins, Integral Capital Partners, New Science Ventures

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series J
- Integral Capital Partners (https://capitalatlas.ai/funds/integral-capital-partners) — Series J
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series J